Compare Costco Wholesale Corporation (COST) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

Costco Wholesale Corporation (COST) trades at $961.85, up 1.86% in the last session, with a neutral technical signal. The stock exhibits strong fundamentals, including consistent revenue growth to $275.24 billion in 2025 and a net income margin of 3.01%. Recent news highlights a membership fee hike and robust March sales growth of 11.3% year-over-year, signaling operational strength.

The outlook remains positive due to steady earnings beats and analyst consensus favoring a buy rating with a $1,120 price target. Key risks include high valuation multiples like a P/E of 47.77 and competitive pressures in retail. Investors should weigh growth prospects against premium pricing for balanced exposure.

Ginkgo Bioworks (DNA) trades at $7.21, down 3.99% on the day, reflecting a bearish technical trend. The company reported Q2 2026 revenue of $20 million, a 48% year-over-year decline, as it shifts focus to autonomous labs and contract research. Despite beating EPS estimates in two of the last three quarters, it remains deeply unprofitable with a net income margin of -219.6% in 2025. Analyst sentiment is mixed with a 45% buy rating, but institutional selling and negative cash flows highlight significant challenges.

The outlook is cautious. While the pivot to new business lines offers long-term potential, near-term execution risks and persistent losses pose substantial downside. Investors face high volatility amid uncertain revenue growth and cash burn, requiring careful risk assessment against any speculative recovery thesis.